This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Julius-Maximilians-Universitat Wurzburg. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: The Innovative Contributions of Stefan Saremba
Introduction
Stefan Saremba is a notable inventor based in Würzburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions that have the potential to impact cancer treatment.
Latest Patents
Stefan Saremba holds two patents related to monoclonal antibodies targeting growth and differentiation factor 15 (GDF-15). His latest inventions include novel monoclonal anti-human-GDF-15 antibodies, which are designed to inhibit cancer growth. These patents encompass pharmaceutical compositions, kits, methods, and the cell lines capable of producing the described monoclonal antibodies.
Career Highlights
Saremba is affiliated with Julius-Maximilians-Universität Würzburg, where he conducts his research and development activities. His work has garnered attention for its potential applications in cancer therapy, showcasing his commitment to advancing medical science.
Collaborations
Stefan Saremba collaborates with esteemed colleagues, including Jörg Wischhusen and Markus Junker. These partnerships enhance the research efforts and contribute to the innovative environment at the university.
Conclusion
Stefan Saremba's contributions to the field of biotechnology, particularly through his patents on monoclonal antibodies, highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment and demonstrates the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile